Week 529 Review - Good week despite some big drops.

Not a bad week, with some decent rises making up for some depressing drops. The deficit between cost and value narrowed by £4,005 to £142,246 and the deficit between injection and value reduced to £63,416. Total portfolio value increased to £112,816.

Worst performer was last week's Share of the Week CWR:Ceres Power, which dropped 11% after lackluster interims and likely profit taking following the 44% rise last week.

TRX:Tissue Regenix had a 2nd big drop in a row, falling 9% to go 85% down.

PBX:Probiotix Health dropped 7% and will likely continue to drift until there is some news.

AMP:Ampeak Energy fell 5% after their interim results to go 74% down.

TLOU:Tlou Energy continue to yo-yo and dropped 5% this week to go 36% down.

CAPD:Capital rose 5% and it was a lot more than that in mid-week, allowing me to sell my SIPP holding. My remaining dealing account holding is 10% down and hopefully I can sell it soon.

RIO:Rio Tinto went up 5% but still seems to be lagging the other miners. My holding is only 4% down and I'm tempted to buy more when my pension transfer comes in a couple of weeks.

FDM:FDM Group recovered 6% of their recent losses but are still 60% down.

BOKU:Boku climbed an impressive 7% and are now 13% in profit.

GGP:Greatland Resources went up 10% and are 25% in profit.

IES:Invinity Energy went up 10% after revealing quite a few projects to deliver their batteries may be eligible for grant aid.

CORE:Solidcore Resources finally seems to be catching up with the other gold miners, and climbed 15%, but my holding is still 76% down.

Share of the Week is OPTI:Optibiotix which went up 17%, helped by the CEO buying a load of shares and possibly in anticipation of Sweetbiotix news in the next few weeks.

Here's the ISA and shares portfolio after week 9 of year 11.

			Weekly Change
Cash	£73.08		+£0
Portfolio cost	£115,878.07		+£0
Portfolio sell value (bid price-commission)	£37,945.50	(-67.3%)	+£1,691.14
Potential profits	£128.60		+£74.25
Yr 11 Dividends	£0		+£0
Yr 11 Interest	£0.02		+£0
Yr 11 Profit from sales	£0		+£0
Yr 11 proj avg monthly profit	-£7.69	(-0.1%)	+£0.96
Total Dividends	£12,488.07		+£0
Total Interest	£8.59		+£0
Total Profit from sales	£17,560.27		+£0
Average monthly cash profit	£241.44	(3.3%)	-£0.46
(Sold stocks profit + Dividends - Fees / Months)

Potential profits went up £74 thanks to BOKU:Boku and total value went up a healthy £1,691. Year 11 performance should go positive in 2 weeks when a CAPD:Capital dividend comes through, but meantime is negative due to ISA fees.

Will it last more than a week?

Still below the trend line.

The SIPP looks like this after week 513 overall and week 45 of year 10.

			Weekly Change
Cash	£1,642.70		-£27.64
Portfolio cost	£137,470.05		+£239.26
Portfolio sell value (bid price - commission)	£73,155.64	(-46.8%)	+£2,314.24
Potential profits	£6,800.20		+£281.04
Yr 10 Dividends	£1,658.24		+£91.24
Yr 10 Interest	£4.00		+£0
Yr 10 Profit from sales	£6,948.31		+£57.88
Yr 10 proj avg monthly profit	£809.90	(10.9%)	-£3.72
Total Dividends	£17,774.89		+£91.24
Total Interest	£16.90		+£0
Total Profit from sales	£23,956.25		+£57.88
Average monthly cash profit	£339.29	(4.5%)	+£0.60

I sold my CAPD:Capital shares as they have fallen out of my top 50 in the magic formula and they had a brief spike in mid-week to allow me to take a profit. I sold 1,123 shares at 104.1p making £57.88 (5.2%) profit, or 7% if you include the £21 dividend, with another dividend still to come.

I bought 127 shares in KNOS:Kainos Group at 878.7p costing £1,133.48. They went up 1% after I bought them, but are 1% down due to commission. They are 9th on my magic formula ranking, but I had avoided them due to a long decline in share price. However they recently surged so seem to have some upward momentum. They pay a 3.87% dividend, have ROI of 20.79%, debt to equity of 4.03% and 5-year earnings per share growth of 13.31%. I now have 18 of my top 30 ranking shares, with 9 on my watch list and 3 written off for ethical or red flag reasons.

I also got a tax rebate in my AJ Bell account, so once again bought some more JLP:Jubilee Metals shares. I bought 6,584 at 3.0375p costing £204.99.

I had a £21 dividend from ARBB:Arbuthnot Banking, £43 from RIO:Rio Tinto, and £26 from SBRE:Sabre Insurance.

Year 10 performance remains above 10% with just 7 weeks of the year left to go, but long term profit remained flat at 4.5%, which is unchanged since the beginning of year 10, mainly because the cost of the portfolio has gone up quite a lot with regular injections.

I just can't close the gap to the injection line.

As with the ISA, still below the trend line

Trend line still upwards and we're above it.

Both JLP:Jubilee Metals and OPTI:Optibiotix are due an update in the next few weeks. JLP on copper production and progress on selling the South African operation, and OPTI on 2nd generation products. Seed Health have put out a teaser that they're launching something on 30th September. Could it possibly be the first product to contain Sweetbiotix? Probably not given the serial disappointment we're going through at the moment. It's nice to dream though.

Week 528 Review - Reasonable week spoiled by Optibiotix.

A reasonably good week ruined by OPTI:Optibiotix dropping 1.5p, undoing all the good from elsewhere and causing the deficit between cost and value to widen by £1,393 to a record £146,252, with the deficit between injection and value growing to £67,633. Total portfolio value dropping to £108,599.

Worst performer was last week's Share of the Week TLOU:Tlou Energy which fell 15% and undid last week's rise.

OPTI:Optibiotix dropped 10% which is about £3,000 so it's a good job other things went up.

TRX:Tissue Regenix dropped another 8% as they spiral away towards nothing.

FOUR:4imprint reversed the recent recovery and dropped 6% to go 29% down.

ARBB:Arbuthnot Banking dropped 5% to go 10% down just as I thought they were getting back into profit.

CORE:Solidcore Resources went up 6% but are still 79% down. I really need these to re-list in UK.

IPX:Impax Asset Management recovered last week's losses and went up 6% but are still 59% down.

GGP:Greatland Resources also recovered from last week's drop to go up by 7% and are now 14% in profit.

FXPO:Ferrexpo recovered 9% so are 89% down which means I have to report on them again.

AFC:AFC Energy recovered 10% and are now only 35% down.

ALU:Alumasc Group recovered 10% after recent drops and are now 71% up.

PAF:Pan African Resources continue to surprise, climbing another 10% to go 176% up as they prepare to list on the main market which should see them enter the FTSE index.

Share of the Week is CWR:Ceres Power which climbed a massive 44%, although my holding is still 34% down. Maybe things are starting to look up here.

Here's the ISA and shares portfolio after week 8 of year 11.

			Weekly Change
Cash	£73.08		-£8.00
Portfolio cost	£115,878.07		+£0
Portfolio sell value (bid price-commission)	£36,254.36	(-68.7%)	-£1,134.25
Potential profits	£54.35		+£0
Yr 11 Dividends	£0		+£0
Yr 11 Interest	£0.02		+£0.02
Yr 11 Profit from sales	£0		+£0
Yr 11 proj avg monthly profit	-£8.65	(-0.1%)	-£3.72
Total Dividends	£12,488.07		+£0
Total Interest	£8.59		+£0.02
Total Profit from sales	£17,560.27		+£0
Average monthly cash profit	£241.90	(3.3%)	-£0.53
(Sold stocks profit + Dividends - Fees / Months)

Cash dropped due to monthly fees and BOKU:Boku stayed flat so no change in potential profits.

And still the decline continues.

Dropping faster than the trend line now and almost off the bottom of the chart.

The SIPP looks like this after week 512 overall and week 44 of year 10.

			Weekly Change
Cash	£1,670.34		-£469.27
Portfolio cost	£137,230.79		+£484.47
Portfolio sell value (bid price - commission)	£70,602.14	(-48.6%)	-£259.25
Potential profits	£6,519.16		+£976.29
Yr 10 Dividends	£1,567.00		+£34.93
Yr 10 Interest	£4.00		+£0.04
Yr 10 Profit from sales	£6,890.43		+£0
Yr 10 proj avg monthly profit	£813.62	(10.9%)	-£17.39
Total Dividends	£17,683.65		+£34.93
Total Interest	£16.90		+£0.04
Total Profit from sales	£23,898.37		+£0
Average monthly cash profit	£338.69	(4.5%)	-£0.54

Although I was away on holiday, my monthly regular savings kicked in.

The first was BEZ:Beazley where I bought 31 shares at 797.26p costing £249.89. That reduced my weighted average to 926.73p. They went up to 837p just after I bought them, so my holding is only 11% down now.

The next purchase was a new investment. I bought 13 share in RAT:Rathbones at 1784p costing £234.58. These climbed to 1810p by the end of the week so I'm only 2% down due to commission. They are 23rd in my magic formula ranking, with dividend of 5.34%, ROI of 11.4%, debt to equity of 6.51% and 5 year earnings per share growth of 4.4%. Their share price had been rising steadily for 6 months before a blip at the end of August. I don't see them soaring, but hope they will be a reliable dividend payer.

I'm a bit miffed that one of my potential magic formula shares KNOS:Kainos Group which I was going to buy, I held back because their share price had been relentlessly declining. A few weeks ago it leapt from 700p to 900p so it goes to show it occasionally pays to catch a falling knife.

I got a £10 dividend from CKN:Clarkson and £24 from FOUR:4imprint, but also paid monthly fees. Value only dropped by £259 and potential profits zoomed up £976 thanks to my gold miners and ALU:Alumasc.

Still heading the wrong way.

Still below the trend line but at least no longer steeper than it.

I'm hoping this will stay fairly flat for a while now, as I don't really want to sell any more of my profitable shares. The next opportunity will probably be if CAPD:Capital continues to rise or if JLP:Jubilee Metals ever sorts itself out.

My biggest holdings are in a right mess at the moment, which is why I have a record deficit. OPTI:Optibiotix is at 9p and contributing £95,289 towards my deficit, which is 65% of it. My next biggest holding is JLP:Jubilee Metals which is contributing £20,893 to the deficit, which is 14% of it. Then we have PBX:Probiotix Health contributing £13,541 which is 9%. That means 88% of my losses are down to just 3 companies. If they could get to break-even my losses would only be £17,500 which would cause me to sleep easy. I would also be £61K above my injection line. The good news is that I'm reasonably confident all three will eventually come good, but I don't know how long it's going to take, and I'm fed up of writing doom and gloom week in and week out as my portfolio slides relentlessly downwards. I can just take heart that my new SIPP investments are doing much better and I have a process for buying shares which I hope will mean any new money is less likely to lose as much value as my previous purchases. 

Week 527 Review - Another losing week despite gold stocks rising well.

Another losing week, with the deficit between cost and value widening by £2,500 yo £144,858 and the deficit between injection and value widening to £66,246. Total portfolio value dropped to £109,986.

My biggest loser and a major contributor to the losses was CAML:Central Asia Metals which fell a massive 16% after lackluster results and a having of the dividend. A cynic might argue that they engineered the share price drop as they have instigated a share buy-back. It's very frustrating as I recently bought a load more and am now back to a big paper loss.

TRX:Tissue Regenix dropped 14% and I'm beginning to think I'll never get anything back from these as they are 82% down.

AMP:Ampeak Energy dropped 8% to go 72% down.

GGP:Greatland Resources suffered from some profit taking and dropped 5% but are still 7% up.

OPTI:Optibiotix continued to slide, and fell another 5% this week.

There was a lot more good news than last week, with INVP:Investec climbing 5% to go 2% into profit.

PRU:Prudential climbed 5% just one week after I bought them and are 5% in profit.

CORE:Solidcore Resources finally started reacting to the price of gold and went up 10%, but are still 80% down.

IES:Invinity Energy climbed 10% as they sold a few more batteries.

PAF:Pan African Resources continued to climb, rising another 10% to go 152% up.

SBTX:SkinBioTherapeutics had a rare rise of 10% but are still 28% down.

Share of the Week is TLOU:Tlou Energy, which does tend to bounce around a lot, but rose 13% this week.

Here's the ISA and shares portfolio after week 7 of year 11.

			Weekly Change
Cash	£81.08		+£0
Portfolio cost	£115,878.07		+£0
Portfolio sell value (bid price-commission)	£37,388.61	(-67.7%)	-£553.14
Potential profits	£54.35		-£14.85
Yr 11 Dividends	£0		+£0
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£0		+£0
Yr 11 proj avg monthly profit	-£4.93	(-0.1%)	+£0.82
Total Dividends	£12,488.07		+£0
Total Interest	£8.57		+£0
Total Profit from sales	£17,560.27		+£0
Average monthly cash profit	£242.43	(3.4%)	-£0.46
(Sold stocks profit + Dividends - Fees / Months)

Not much happened while I was on holiday. Potential profits dropped £14 as BOKU:Boku fell yet again. £553 drop in value is pretty flat.

Still looks dreadful

Still below the trend line.

The SIPP looks like this after week 511 overall and week 43 of year 10.

			Weekly Change
Cash	£2,139.61		+£0
Portfolio cost	£136,746.32		+£0
Portfolio sell value (bid price - commission)	£70,376.92	(-48.5%)	-£1,947.45
Potential profits	£5,542.87		+£92.65
Yr 10 Dividends	£1,532.07		+£0
Yr 10 Interest	£3.96		+£0
Yr 10 Profit from sales	£6,890.43		+£0
Yr 10 proj avg monthly profit	£831.01	(11.1%)	-£19.79
Total Dividends	£17,648.72		+£0
Total Interest	£16.86		+£0
Total Profit from sales	£23,898.37		+£0
Average monthly cash profit	£339.23	(4.5%)	-£0.66

Massive drop in value compared to the ISA because I hold so much CAML:Central Asia Metals in this account, and potential profit only went up £92 as the gains in miners were offset by losses elsewhere.

Bad.

Dreadful.

Nice.

Another holiday catch-up week so nothing more to say.

Week 526 Review - Gold miners shine but not enough to recover a dreadful week elsewhere.

A pretty dreadful week across most of the portfolio, with gold miners the only ray of sunshine. The deficit between cost and value widened by £4,679 to £142,358 and the deficit between injection and value widened to £63,746. Total portfolio value dropped to £112,486.

Worst performer was PBX:Probiotix Health, dropping 13% despite pretty good results.

CWR:Ceres Power fell 12% and are now 54% down.

ALU:Alumasc Group dropped 9% and I really don't know why, but are still 53% up.

ASHM:Ashmore Group have been recovering slightly recently but all that was undone as they dropped 9% to go 42% down.

OPTI:Optibiotix also dropped 9% which caused a significant proportion of this week's losses.

IPX:Impax Asset Management fell 6% and are now 62% down, all on the back of the St James's Place contract loss, which seems way too big a drop as it was only about 15% of their income.

JLP:Jubilee Metals didn't rally for very long and dropped 6% this week, which was another big contributor to the losses.

AFC:AFC Energy fell 5% to go 40 % down.

FXPO:Ferrexpo also fell 5% to go 89% down which is just shy of the 90% where I'll no longer have to report on it.

IHP:Integrafin dropped 5% and are no longer in profit, but down 3% on my purchase price.

My only significan risers were my two gold miners. PAF:Pan African Resources climbed 11% to go 120% up, and Share of the Week goes to GGP:Greatland Resources which climbed 17% to go 12% into profit.

Here's the ISA and shares portfolio after week 6 of year 11.

			Weekly Change
Cash	£81.08		+£0
Portfolio cost	£115,878.07		+£0
Portfolio sell value (bid price-commission)	£37,941.75	(-67.3%)	-£2,521.31
Potential profits	£69.20		-£19.80
Yr 11 Dividends	£0		+£0
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£0		+£0
Yr 11 proj avg monthly profit	-£5.75	(-0.1%)	+£1.16
Total Dividends	£12,488.07		+£0
Total Interest	£8.57		+£0
Total Profit from sales	£17,560.27		+£0
Average monthly cash profit	£242.89	(3.4%)	-£0.46
(Sold stocks profit + Dividends - Fees / Months)

BOKU:Boku dropped again so potential profits slipped by £19, and a thumping great drop in value.

All the recent gains have gone.

Nearly got to the trend line, but back below it now.

The SIPP looks like this after week 510 overall and week 42 of year 10.

			Weekly Change
Cash	£2,139.61		+£411.74
Portfolio cost	£136,746.32		+£564.73
Portfolio sell value (bid price - commission)	£72,324.37	(-47.1%)	-£2,158.67
Potential profits	£5,450.22		-£40.01
Yr 10 Dividends	£1,532.07		+£0
Yr 10 Interest	£3.96		+£0
Yr 10 Profit from sales	£6,890.43		+£726.47
Yr 10 proj avg monthly profit	£850.80	(11.4%)	+£56.03
Total Dividends	£17,648.72		+£0
Total Interest	£16.86		+£0
Total Profit from sales	£23,898.37		+£726.47
Average monthly cash profit	£339.89	(4.6%)	+£5.52

I decided my holding in III:3i Group had run its course. The premium to NAV is way over what it should be and they are utterly reliant on one investment, and I'd already sold half my original holding so dividend income was only going to be against 32 shares. I sold them for 3883.4p making £726.47 (140.7%) profit.

I used some of the proceeds to buy 110 shares in PRU:Prudential for 968.744p costing £1,075.95. I know they are not on my magic formula listing, but I've always wanted to invest and they are increasing in value at the moment, and are planning on selling off part of the company so there may be some shareholder returns.

Despite cashing in £726 profit, potential profit only dropped £40 thanks to the gold miners climbing so much. With just 10 weeks of year 10 left to go, my profit is 11.4% which is brilliant, but long term profit hardly budged and is half my target 10%. Cash went up £411 partly from the III sale and also from my £250 monthly savings.

Not looking as bad as the ISA

That is looking as bad as the ISA.

I'm liking this chart though!

Nothing more to say this week as I've been on holiday so catching up 3 weeks at once.